MyChesCo on MSN4d
FDA Approves GSK’s Blujepa as First New Oral Antibiotic for UTIs in 30 Years
The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for ...
Here’s what to know about Blujepa, the new FDA-approved UTI treatment heading to market this year
Drugmaker GSK plans to release the drug in the U.S. in the second half of 2025. Blujepa, the brand name for gepotidacin, is ...
New Atlas5d
First new stroke and UTI drugs in 30 years get FDA approval
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
Endocrinology Advisor3d
FDA Approves Blujepa for Uncomplicated UTI in Female Patients
The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.
Medindia1d
Blujepa: First New Oral UTI Antibiotic in 30 Years
Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...
The American Journal of Managed Care10d
FDA Approves First New Class of Oral Antibiotics for Uncomplicated UTIs in Nearly 30 Years
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
McKnight's Long-Term Care News8d
FDA approves gepotidacin antibiotic for uncomplicated urinary tract infections
The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...
US FDA approves antibiotic for urinary tract infections: Why it helps with recurrent infection
Lifestyle adjustments can help prevent UTIs. While not a proven cure, cranberry products and D-mannose supplements may help ...
CNN10d
Millions of women get painful UTIs that keep coming back. A new kind of antibiotic may help break the cycle
The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be available in the second half of 2025.
Healio9d
FDA approves first new antibiotic for uncomplicated UTIs in nearly 30 years
The FDA approved gepotidacin for the treatment of uncomplicated UTIs in women and adolescent girls aged 12 years or older, ...
HealthDay on MSN10d
FDA Approves Blujepa for Uncomplicated Urinary Tract Infections
TUESDAY, March 25, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the ...
clinicaladvisor.com9d
FDA Approves Blujepa for Uncomplicated UTI in Female Patients
Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes. Study participants were ...